New: the Dotquad blog, with a free tool at the end of every post

Autonomous system

AS6095 Novartis Institutes for BioMedical Research, Inc.

AS6095 is operated by Novartis Institutes for BioMedical Research, Inc. (novartis.com), registered in United States. It announces 2 IPv4 prefixes covering 1,024 addresses and 0 IPv6 prefixes.

ASN
AS6095
Owner
Novartis Institutes for BioMedical Research, Inc.
Domain
novartis.com
Country
United States (US)
IPv4 addresses
1,024
IPv6 prefixes
0

RPKI route authorisation

Every block AS6095 announces is covered by its route origin authorisations (ROAs). ROAs published through RIPE NCC, ARIN.

RPKI lets the holder of an address block publish which networks may announce it, so others can reject hijacked or mistaken routes. This shows how the ROAs cover each block in our data. Those blocks merge neighbouring announcements, so it isn't a check of each individual route, and ROAs' maximum lengths aren't checked.

Validated ROAs from the five regional registries, via the rpki-client console, built Nov 22, 2026. Shown for information only. Credits.

IPv4 prefixes 2

Get this as JSON

The same data from the API, with every prefix. The ASN endpoint is part of the Pro plan, coming soon. Get a free key now for IP lookups.

curl https://api.dotquad.app/v1/asn/6095 \
  -H "Authorization: Bearer $DOTQUAD_KEY"

Prefixes and registration from IPtoASN (public domain), updated Nov 22, 2026. Owner name and domain from IPinfo Lite (CC BY-SA 4.0). Credits.